Skip to main content
Smart Investors Daily
The Cooper Companies, Inc. logo

NYSE · COO

The Cooper Companies, Inc.

Healthcare · Medical - Instruments & Supplies

$60.33

Down-$0.42 (-0.69%)

Updated Nov 20, 2026, 2:01 AM

SID Score

4.5/10

Composite research score

Smart Money

58/100

Neutral

Market cap
16.38B
P/E ratio
43.38
Dividend yield
0.00%
52-week range
$51.01 – $84.62
Volume
2.1M
Avg. volume
2.86M

Price performance · COO

COO price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 19, 2026

COO closed at $60.33 after 21 trading sessions, down 2.14% for the selected period.

Last close
$60.33
Period change
-2.14%
Period low
$59.41
Period high
$64.42
Daily close
View OHLC price history
COO OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 19, 2026$60.25$60.79$59.715$60.332.1M
Nov 18, 2026$60.03$61.315$59.26$60.752.2M
Nov 17, 2026$61.30$62.00$60.615$60.721.78M
Nov 16, 2026$63.06$63.175$61.795$61.881.84M
Nov 13, 2026$62.83$63.03$62.144$62.651.57M
Nov 12, 2026$63.26$63.50$62.11$62.191.95M
Nov 11, 2026$62.67$63.11$62.28$62.931.68M
Nov 10, 2026$63.235$63.80$62.83$63.571.77M
Nov 9, 2026$62.88$64.305$62.50$63.932.35M
Nov 6, 2026$61.57$62.80$61.52$62.362.06M
Nov 5, 2026$65.40$65.53$62.39$63.512.38M
Nov 4, 2026$62.44$64.76$62.12$64.423.27M
Nov 3, 2026$60.89$61.23$60.22$60.832.2M
Nov 2, 2026$60.11$61.48$59.9154$61.302.44M
Oct 30, 2026$60.64$61.08$59.01$59.557.89M
Oct 29, 2026$60.04$60.44$59.57$60.341.76M
Oct 28, 2026$58.70$60.29$58.501$59.414.24M
Oct 27, 2026$60.95$60.95$59.48$59.882.17M
Oct 26, 2026$61.21$62.09$60.83$61.141.83M
Oct 23, 2026$61.28$61.735$60.46$61.211.82M
Oct 22, 2026$59.39$61.66$59.27$61.653.51M

Latest COO news

The latest Smart Investors Daily articles mentioning COO.

COO research

Overview

Company profile and research snapshot.

Company profile

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$91.67
Implied upside
—
Analysts
—
COO recent ratings
DateFirmRatingTarget
Oct 7, 2026BarclaysEqual-Weight—
Sep 15, 2026NeedhamBuy—
Sep 11, 2026MizuhoOutperform—
Sep 10, 2026JP MorganNeutral—
Sep 10, 2026Piper SandlerNeutral—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 9, 2026

Lifevantage (LFVN) Surpasses Q1 Earnings Estimates

Lifevantage (LFVN) delivered earnings and revenue surprises of +66.67% and -3.84%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Yahoo · Nov 5, 2026

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2026

SAN RAMON, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report fourth quarter and full year 2026 financial results on Thursday, December 3, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments. The dial-in number for the call is 800-715-9871 and the conference ID is 1193290. A simultaneous audio webcast

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.